241 related articles for article (PubMed ID: 21980433)
21. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor.
Xu BC; Wang X; Darus CJ; Kopchick JJ
J Biol Chem; 1996 Aug; 271(33):19768-73. PubMed ID: 8702683
[TBL] [Abstract][Full Text] [Related]
22. Determinants of growth hormone receptor down-regulation.
Deng L; He K; Wang X; Yang N; Thangavel C; Jiang J; Fuchs SY; Frank SJ
Mol Endocrinol; 2007 Jul; 21(7):1537-51. PubMed ID: 17488973
[TBL] [Abstract][Full Text] [Related]
23. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
[TBL] [Abstract][Full Text] [Related]
24. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
25. Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.
Strous GJ; Almeida ADS; Putters J; Schantl J; Sedek M; Slotman JA; Nespital T; Hassink GC; Mol JA
Front Endocrinol (Lausanne); 2020; 11():597573. PubMed ID: 33312162
[TBL] [Abstract][Full Text] [Related]
26. Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.
Uyttendaele I; Lemmens I; Verhee A; De Smet AS; Vandekerckhove J; Lavens D; Peelman F; Tavernier J
Mol Endocrinol; 2007 Nov; 21(11):2821-31. PubMed ID: 17666591
[TBL] [Abstract][Full Text] [Related]
27. A designed cell-penetrating human SOCS2 protein suppresses GH-dependent cancer cell proliferation.
Miyamoto A; Masuhiro Y; Seki T; Hanazawa S; Shiba H
Biosci Biotechnol Biochem; 2019 Feb; 83(2):300-308. PubMed ID: 30343638
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage.
Cowan JW; Wang X; Guan R; He K; Jiang J; Baumann G; Black RA; Wolfe MS; Frank SJ
J Biol Chem; 2005 May; 280(19):19331-42. PubMed ID: 15743767
[TBL] [Abstract][Full Text] [Related]
29. Cytokine-inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice.
González L; Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2002 Feb; 143(2):386-94. PubMed ID: 11796490
[TBL] [Abstract][Full Text] [Related]
30. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
Yang HL; Sun C; Sun C; Qi RL
Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
[TBL] [Abstract][Full Text] [Related]
31. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
33. Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2.
Alves dos Santos CM; ten Broeke T; Strous GJ
J Biol Chem; 2001 Aug; 276(35):32635-41. PubMed ID: 11418602
[TBL] [Abstract][Full Text] [Related]
34. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.
Jensik PJ; Arbogast LA
Mol Cell Endocrinol; 2015 Feb; 401():130-41. PubMed ID: 25448846
[TBL] [Abstract][Full Text] [Related]
36. SOCS2 regulation of growth hormone signaling requires a canonical interaction with phosphotyrosine.
Li K; Meza Guzman LG; Whitehead L; Leong E; Kueh A; Alexander WS; Kershaw NJ; Babon JJ; Doggett K; Nicholson SE
Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36398696
[TBL] [Abstract][Full Text] [Related]
37. Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.
Kazi JU; Rönnstrand L
Mol Oncol; 2013 Jun; 7(3):693-703. PubMed ID: 23548639
[TBL] [Abstract][Full Text] [Related]
38. GHR signalling: Receptor activation and degradation mechanisms.
Chhabra Y; Lee CMM; Müller AF; Brooks AJ
Mol Cell Endocrinol; 2021 Jan; 520():111075. PubMed ID: 33181235
[TBL] [Abstract][Full Text] [Related]
39. Multimeric growth hormone receptor complexes serve as signaling platforms.
Sedek M; van der Velden LM; Strous GJ
J Biol Chem; 2014 Jan; 289(1):65-73. PubMed ID: 24280222
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis.
DiFedele LM; He J; Bonkowski EL; Han X; Held MA; Bohan A; Menon RK; Denson LA
Gastroenterology; 2005 May; 128(5):1278-91. PubMed ID: 15887111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
